Stereotactic Body Radiotherapy (SBRT) for liver metastasis – clinical outcomes from the international multi-institutional RSSearch® Patient Registry
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1748-717X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Stereotactic Body Radiotherapy (SBRT) for liver metastasis – clinical outcomes from the international multi-institutional RSSearch® Patient Registry ; volume:13 ; number:1 ; day:13 ; month:2 ; year:2018 ; pages:1-11 ; date:12.2018
Radiation oncology ; 13, Heft 1 (13.2.2018), 1-11, 12.2018
- Urheber
-
Mahadevan, Anand
- Beteiligte Personen und Organisationen
-
Blanck, Oliver
Lanciano, Rachelle
Peddada, Anuj
Sundararaman, Srinath
D’Ambrosio, David
Sharma, Sanjeev
Perry, David
Kolker, James
Davis, Joanne
SpringerLink (Online service)
- DOI
-
10.1186/s13014-018-0969-2
- URN
-
urn:nbn:de:101:1-2018090914571257325630
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mahadevan, Anand
- Blanck, Oliver
- Lanciano, Rachelle
- Peddada, Anuj
- Sundararaman, Srinath
- D’Ambrosio, David
- Sharma, Sanjeev
- Perry, David
- Kolker, James
- Davis, Joanne
- SpringerLink (Online service)
Ähnliche Objekte (12)
Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases
Correction to: Stereotactic Ablative Radiotherapy (SABR/SBRT) for Hepatocellular Carcinoma
Treatment of metastatic breast cancer by stereotactic body radiotherapy (SBRT) and stereotactic radiosurgery (SRS)
Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma
Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)
Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases: a pooled analysis of the German working group "stereotactic radiotherapy"
Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments
Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma
Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases
Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-Alone in Unresectable Hepatocellular Carcinoma
Stereotactic body radiotherapy (SBRT) for pulmonary metastases from renal cell carcinoma: a multicenter analysis of the German working group “Stereotactic Radiotherapy”
Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients
Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases
Correction to: Stereotactic Ablative Radiotherapy (SABR/SBRT) for Hepatocellular Carcinoma
Treatment of metastatic breast cancer by stereotactic body radiotherapy (SBRT) and stereotactic radiosurgery (SRS)
Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma
Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)
Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases: a pooled analysis of the German working group "stereotactic radiotherapy"
Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments
Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma
Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases
Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-Alone in Unresectable Hepatocellular Carcinoma
Stereotactic body radiotherapy (SBRT) for pulmonary metastases from renal cell carcinoma: a multicenter analysis of the German working group “Stereotactic Radiotherapy”
Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients
Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases
Correction to: Stereotactic Ablative Radiotherapy (SABR/SBRT) for Hepatocellular Carcinoma
Treatment of metastatic breast cancer by stereotactic body radiotherapy (SBRT) and stereotactic radiosurgery (SRS)
Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma
Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)
Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases: a pooled analysis of the German working group "stereotactic radiotherapy"
Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments
Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma
Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases
Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-Alone in Unresectable Hepatocellular Carcinoma
Stereotactic body radiotherapy (SBRT) for pulmonary metastases from renal cell carcinoma: a multicenter analysis of the German working group “Stereotactic Radiotherapy”